Abstract
The effect of corticotrophin suspended in gelatin in doses varying from 40 to 400 i.u. on the plasma 11-hydroxycorticosteroid response has been investigated in volunteer subjects in order to determine the optimum dose required to produce prolonged and continuous adrenocortical stimulation using this preparation. Increasing the dose of corticotrophin beyond 200 i.u. did not produce a greater intensity or prolongation of adrenocortical stimulation; 300 i.u. corticotrophin in 7·5 ml. of gelatin produced the same effect as 310 i.u. in 1 ml. gelatin. In order to achieve prolonged and continuous adrenal stimulation the optimum dose of corticotrophin would appear to be 200 i.u., which could be suspended in 1 ml. of gelatin for ease of administration, and which produced adrenal stimulation for approximately 36 hours. The effect of the administration of a single large dose of corticotrophin has been investigated in 13 asthmatic patients during an exacerbation. All had failed to respond to conventional therapy but responded to corticotrophin with one exception. Five patients required no more than two injections for a sustained remission. Seven were discharged needing prolonged corticotrophin in conventional doses. The advatage of using this form of corticotrophin therapy over a short course of high-dosage corticosteroid therapy is discussed.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BAYLISS R. I., STEINBECK A. W. The adrenal response to corticotrophin; effect of A.C.T.H. on plasma adrenal steroid levels. Br Med J. 1954 Feb 27;1(4860):486–490. doi: 10.1136/bmj.1.4860.486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BLACK S., FRIEDMAN M. ADRENAL FUNCTION AND THE INHIBITION OF ALLERGIC RESPONSES UNDER HYPNOSIS. Br Med J. 1965 Feb 27;1(5434):562–567. doi: 10.1136/bmj.1.5434.562. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CAMERON E. A., KILBORN J. R. PLASMA CORTISOL AND CORTICOSTERONE RESPONSE TO INFUSED CORTICOTROPHIN IN NORMAL SUBJECTS. Clin Chim Acta. 1964 Oct;10:308–313. doi: 10.1016/0009-8981(64)90060-9. [DOI] [PubMed] [Google Scholar]
- Friedman M. The effect of corticotrophin on hypothalmic-pituitary-adrenal function of children. Proc R Soc Med. 1968 Mar;61(3):291–293. doi: 10.1177/003591576806100340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Houck J. C., Patel Y. M. Proposed mode of action of corticosteroids on the connective tissue. Nature. 1965 Apr 10;206(980):158–160. doi: 10.1038/206158a0. [DOI] [PubMed] [Google Scholar]
- KASS I., APPLEBY S. The status of the adrenal gland in the asthmatic patient. Am J Med Sci. 1960 Aug;240:213–218. [PubMed] [Google Scholar]
- MATTINGLY D. A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. J Clin Pathol. 1962 Jul;15:374–379. doi: 10.1136/jcp.15.4.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NABARRO J. D. The pituitary and adrenal cortex in general medicine. Br Med J. 1960 Aug 20;2(5198):553–558. doi: 10.1136/bmj.2.5198.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nelson J. K., Mackay J. S., Sheridan B., Weaver J. A. Intermittent therapy with corticotrophin. Lancet. 1966 Jul 9;2(7454):78–83. doi: 10.1016/s0140-6736(66)91806-x. [DOI] [PubMed] [Google Scholar]
- ROBSON A. O., KILBORN J. R. STUDIES OF ADRENOCORTICAL FUNCTION IN CONTINUOUS ASTHMA. Thorax. 1965 Jan;20:93–98. doi: 10.1136/thx.20.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SASANO N., KITAGAWA I. CORTICOSTEROID-INDUCED ATROPHY OF THE HUMAN ADRENALS COMPARABLE TO PANHYPOPITUITARISM; A HISTOPATHOLOGICAL STUDY. Tohoku J Exp Med. 1964 Aug 25;83:270–281. doi: 10.1620/tjem.83.270. [DOI] [PubMed] [Google Scholar]
- SCHAYER R. W. A UNIFIED THEORY OF GLUCOCORTICOID ACTION. Perspect Biol Med. 1964;7:71–84. doi: 10.1353/pbm.1964.0006. [DOI] [PubMed] [Google Scholar]
- STONER H. B., WHITELEY H. J. The effects of cortisone and corticotrophin on the human adrenal cortex. Lancet. 1954 Nov 13;267(6846):992–994. doi: 10.1016/s0140-6736(54)90543-7. [DOI] [PubMed] [Google Scholar]
